
Genz Biotech develops diagnostic tests that use genomic and AI analysis to support personalized medicine for complex diseases like cancer. The company is a biotech R&D firm building in vitro diagnostic (IVD) tests and AI-driven genomic data analysis tools for medical centers, genetic diagnostic labs, and end-users. Its technology combines genomic sequencing interpretation, machine learning models for biomarker detection, and IVD platforms. Genz has commercialized multiple IVD genetic tests, obtained regulatory approvals, and collaborated with research centers and international projects. The company targets clinical and research markets and aims to scale diagnostic offerings for precision medicine.

Genz Biotech develops diagnostic tests that use genomic and AI analysis to support personalized medicine for complex diseases like cancer. The company is a biotech R&D firm building in vitro diagnostic (IVD) tests and AI-driven genomic data analysis tools for medical centers, genetic diagnostic labs, and end-users. Its technology combines genomic sequencing interpretation, machine learning models for biomarker detection, and IVD platforms. Genz has commercialized multiple IVD genetic tests, obtained regulatory approvals, and collaborated with research centers and international projects. The company targets clinical and research markets and aims to scale diagnostic offerings for precision medicine.